Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Leena Helle et al.|Journal of Clinical Oncology|2009

Cited by 459